Circulating DNA-Markers of High Risk for Lung Cancer in Patients with Chronic Obstructive Pulmonary Disease
Related Experiment Video
Updated: Jun 4, 2026

MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier (MSC) for Lung Cancer Screening
Published on: October 26, 2017
A A Ponomaryova1, V V Boyarko2, L Wang3
1Cancer Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences, Tomsk, Russia. anastasia-ponomaryova@rambler.ru.
Abstract:
In 26 patients with chronic obstructive pulmonary disease (COPD), validation of the marker genes RARB, ZNF260, and DCDC1 was carried out using liquid biopsy technology. Hypermethylation of RARB, ZNF260, and DCDC1 genes in extracellular DNA of the blood plasma was revealed. Post-therapeutic monitoring showed that hypermethylation of the RARB and/or ZNF260 genes was associated with the development of lung cancer in 23% of cases. These findings show the potential of analyzing the epigenetic markers for assessing the risk of lung cancer development in COPD patients.
Related Concept Videos
Chronic Obstructive Pulmonary Disease I: Introduction
Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History